Points to consider in seeking biosafety approval for research, testing, and environmental release of experimental genetically modified biocontrol products during research and development.

Autor: Tonui WK; Environmental Health Safety Consultancy Ltd., Office 10D, Sifa Towers, Lenana/ Cotton Avenue Junction, Kilimani, Nairobi, Kenya. wtonui@gmail.com., Ahuja V; Biotech Consortium India Limited, New Delhi, India., Beech CJ; Cambea Consulting Ltd, Reading, UK., Connolly JB; Imperial College London, London, UK., Dass B; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Glandorf DCM; GMO Office, National Institute of Public Health and the Environment, Bilthoven, The Netherlands., James S; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Muchiri JN; National Biosafety Authority, Nairobi, Kenya., Mugoya CF; Target Malaria, Kampala, Uganda., Okoree EA; National Biosafety Authority, Accra, Ghana., Quemada H; Western Michigan University, Kalamazoo, MI, USA., Romeis J; Research Division Agroecology and Environment, Agroscope, Zurich, Switzerland.

Publikováno v: Transgenic research [Transgenic Res] 2022 Dec; Vol. 31 (6), pp. 607-623. Date of Electronic Publication: 2022 Oct 04.